Electrophysiology and Cardiac Ablation Device Market Report Suite | Europe | 2019-2025 | MedSuite

  • Year: 2016
  • Scope: 2012-2022
  • Region: Europe
  • Pages: 152
  • Published Date: 10/1/2015
  • Type: MedSuite

Product Description

In 2015, the fastest growing segment in the electrophysiology and ablation market was diagnostic EP catheter devices. Over the forecast period, growth will be driven mostly by the conventional steerable catheter market, which is expected to increase at nearly double digit growth rates every year, partly due to its relatively low price compared to advanced catheters such as loop and mapping catheters. Over the forecast period, the electrophysiology and ablation device market will be driven by the aging population, rise in cardiac ablation procedures and adoption of advanced EP devices. For the relatively newer devices used in electrophysiology and ablation markets, continued education is critical to increase cardiologists’ confidence in these types of cardiac treatments.

The EP market is expected to experience growth across all product segments over the forecast period. The more recent products are expected to experience strong growth on a percentage basis but not on an absolute unit or market growth basis simply because newer devices take a while for physicians to adopt. Also, considering the severity of the procedures, it will take years of practice before a device can fully take off. Therefore, most of the devices sold for newer market segments will go towards training and clinical studies. Throughout the forecast period, there is expected to be a significant growth in demand for catheter-based ablation procedures due to an increase in public knowledge, technological improvements and an increase in the number of EP labs in rural areas.

Biosense Webster was the leading competitor in the EP lab system, ablation catheter and diagnostic EP catheter markets. The company has been able to maintain its dominant position in the market by offering a wide range of EP and ablation devices while utilizing their expansive distribution network to improve sales. The company retains its title as majority market leader in ablation with nearly 50% of the entire market. Other major competitors in the market include Angiodynamics, Biotronik, Boston Scientific, GE Healthcare, MicroPort, Siemens, Stereotaxis, St. Jude Medical and Topera. Certain companies, such as Boston Scientific and St. Jude Medical, also offer a wide range of EP and ablation products and sell them through large distribution networks.

This report also includes an analysis of other factors and trends that have positively and negatively impacted the market.

Electrophysiology and Cardiac Abalation Device Market Report Data Types Included

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Forecasts Until 2022, and Historical Data to 2012
  • Market Drivers & Limiters for Each Device Segment
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors
  • Related Press Releases from Top Competitors

Electrophysiology and Cardiac Abalation Device Companies Analyzed

In 2015, Biosense Webster led the total market for EP and cardiac ablation devices. This was due to their dominance in the lab system, diagnostic EP catheter and cardiac ablation catheter segments. St Jude Medical was the second leading competitor in the EP and cardiac ablation market. They were able to make considerable gains in the diagnostic EP catheter market at Biosense Webster’s expense after the Duo-Decapolar® EP catheter was recalled due to defects.

Other companies researched in this report include Medtronic, GE Healthcare, Siemens, Angiodynamics, Cameron Health, EGI, EsTech, Elmiko Medical, Lepu Medical, MicroPort and various others.

FREE Sample Report

MedtronicSt. Jude MedicalBoston ScientificBiosense WebsterPhilips HealthcareZoll MedicalC.R. BardGE HealthcareCardiac Science

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Explore Options

Report Summary


Select License Type

The electrophysiology and ablation device market includes external defibrillators, ablation catheters, diagnostic electrophysiology (EP) catheters, intracardiac ultrasound (ICE) catheters, electrophysiology (EP) stimulators, diagnostic ECG and cardiac monitoring devices.

  • 2016
  • 2012-2022
  • Europe
  • 10/1/2015
  • 152
  • MedSuite
    Your Cart
    Your cart is emptyReturn to Report Library